<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T04:52:06Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/11765" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/11765</identifier><datestamp>2026-10-18T20:26:45Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>In vivo study of the utility of selective intra-arterial injection of thiopental for neuroprotection in reversible cerebral ischemia</dc:title><dc:creator>Gökten, Murat</dc:creator><dc:creator>Öcal, Osman</dc:creator><dc:creator>Sezer, Can</dc:creator><dc:creator>Zırh, Selim</dc:creator><dc:creator>Muftuoglu, Sevda</dc:creator><dc:creator>Öcal, Elif</dc:creator><dc:creator>Bilginer, Burcak</dc:creator><dc:creator>Arat, Anıl</dc:creator><dc:subject>cerebral ischemia</dc:subject><dc:subject>Degradable starch microsphere</dc:subject><dc:subject>intra-arterial</dc:subject><dc:subject>neuroprotection</dc:subject><dc:subject>thiopental</dc:subject><dc:subject>Animals</dc:subject><dc:subject>Brain Ischemia</dc:subject><dc:subject>Cerebral Infarction</dc:subject><dc:subject>Humans</dc:subject><dc:subject>Injections, Intra-Arterial</dc:subject><dc:subject>Ischemia</dc:subject><dc:subject>Neuroprotective Agents</dc:subject><dc:subject>Rabbits</dc:subject><dc:subject>Cells</dc:subject><dc:subject>Cytology</dc:subject><dc:subject>Microspheres</dc:subject><dc:subject>Neurons</dc:subject><dc:subject>Starch</dc:subject><dc:subject>ketamine</dc:subject><dc:subject>neuroprotective agent</dc:subject><dc:subject>starch microsphere</dc:subject><dc:subject>xylazine</dc:subject><dc:subject>Apoptotic</dc:subject><dc:subject>Glial cells</dc:subject><dc:subject>Group 4</dc:subject><dc:subject>Neuronal cell</dc:subject><dc:subject>Starch microspheres</dc:subject><dc:subject>animal cell</dc:subject><dc:subject>animal experiment</dc:subject><dc:subject>animal model</dc:subject><dc:description>Background: Neuroprotective agents are needed to reduce cerebral damage during surgical or neurointerventional procedures including stroke patients. Purpose: To evaluate if thiopental can be used as a neuroprotective agent when injected intra-arterially in a transient ischemia model. Material and Methods: In total, 24 rabbits were studied as four groups of six animals. Group 1 served as the control group. In group 2, transient ischemia was obtained by intracarotid administration of degradable starch microspheres (DSM). Group 3 was administered thiopental intra-arterially via the carotid artery. Group 4 (experimental group) received both thiopental and DSM intra-arterially. DSM and thiopental were administered through a microcatheter placed into the common carotid artery via the central ear artery access. After sacrifice, apoptotic cells in the cerebral tissues of the animals were evaluated in H&amp;E and TUNEL stained slides. Results: There was a significant increase in the number of apoptotic glial or neuronal cells in group 2 compared to the control group and group 3. The mean number of both the apoptotic neuronal cells (6.8 ± 2.1 vs. 2.5 ± 1.3, P &lt; 0.001) and the apoptotic glial cells (9.4 ± 3.1 vs. 4.6 ± 1.6, P &lt; 0.001) were higher in group 2 compared to group 4. In addition, a higher level of neurological improvement was observed in group 4 compared to group 2 based on neurological assessment score. Conclusion: The intra-arterial administration of thiopental has a protective effect on both glial and neuronal cells during temporary cerebral ischemia in low doses. © The Foundation Acta Radiologica 2023.</dc:description><dc:publisher>SAGE Publications Inc.</dc:publisher><dc:date>2024</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/11765</dc:identifier><dc:identifier>https://doi.org/10.1177/02841851231206503</dc:identifier><dc:identifier>0284-1851</dc:identifier><dc:language>en</dc:language><dc:relation>Acta Radiologica</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/11765</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>